Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06637813
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-09
Brief Title:
Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With DolutegravirLamivudine
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With DolutegravirLamivudine
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NEW_ODOACRE
Brief Summary:
The introduction of combination antiretroviral therapy cART has completely revolutionized the management of HIV-positive patients drastically reducing HIV-associated mortality and morbidity In fact the course of HIV infection has transformed into a chronic disease The availability of different classes of antiretroviral drugs such as nucleoside and non-nucleoside reverse transcriptase inhibitors NRTIs NNRTIs protease inhibitors PIs integrase inhibitors INSTIs and viral entry inhibitors IEs that act in different phases of the HIV life cycle together with careful patient management has allowed us to obtain long-lasting therapeutic efficacy in the vast majority of Italian patients making this infection a chronic disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None